- Home
- KLRS vs RRGB Comparison
KLRS vs RRGB Comparison
Compare KLRS & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- RRGB
- Stock Information
- Founded
- KLRS 2019
- RRGB 1969
- Country
- KLRS United States
- RRGB United States
- Employees
- KLRS N/A
- RRGB N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- RRGB Restaurants
- Sector
- KLRS Health Care
- RRGB Consumer Discretionary
- Exchange
- KLRS Nasdaq
- RRGB Nasdaq
- Market Cap
- KLRS 129.0M
- RRGB 115.3M
- IPO Year
- KLRS N/A
- RRGB 2002
- Fundamental
- Price
- KLRS $2.40
- RRGB $5.11
- Analyst Decision
- KLRS Buy
- RRGB Strong Buy
- Analyst Count
- KLRS 1
- RRGB 4
- Target Price
- KLRS N/A
- RRGB $11.88
- AVG Volume (30 Days)
- KLRS 47.1K
- RRGB 2.5M
- Earning Date
- KLRS 08-15-2025
- RRGB 05-29-2025
- Dividend Yield
- KLRS N/A
- RRGB N/A
- EPS Growth
- KLRS N/A
- RRGB N/A
- EPS
- KLRS N/A
- RRGB N/A
- Revenue
- KLRS N/A
- RRGB $1,252,370,000.00
- Revenue This Year
- KLRS N/A
- RRGB $0.04
- Revenue Next Year
- KLRS N/A
- RRGB N/A
- P/E Ratio
- KLRS N/A
- RRGB N/A
- Revenue Growth
- KLRS N/A
- RRGB N/A
- 52 Week Low
- KLRS $2.32
- RRGB $2.50
- 52 Week High
- KLRS $24.15
- RRGB $8.18
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- RRGB 53.67
- Support Level
- KLRS N/A
- RRGB $4.98
- Resistance Level
- KLRS N/A
- RRGB $5.59
- Average True Range (ATR)
- KLRS 0.00
- RRGB 0.65
- MACD
- KLRS 0.00
- RRGB -0.14
- Stochastic Oscillator
- KLRS 0.00
- RRGB 9.95
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.